Fosun Pharma to acquire 74% stake in Gland Pharma for $1.09 billion
This is in sharp reduction to the previous agreement of "paying no more than USD 50 million contingent consideration for Gland Pharma's Enoxaparin sales in the US market".
Sep 18, 2017, 18:01 PM IST